Alnylam Pharmaceuticals, Inc. (ALNY) Financials

Key financial figures for Alnylam Pharmaceuticals, Inc. (Q4 2025).

Revenue

$1.1B

Net Income

$112M

EPS

$0.84

Total Assets

$5.0B

Operating Cash Flow

$164M

Full income statement, balance sheet, and cash flow for Alnylam Pharmaceuticals, Inc. on SentiSense.